Reducing out-of-pocket costs in a value-based medication plan may modestly improve short-term health outcomes in commercially insured individuals with diabetes.
New Endocrine Society statement with input from other organizations provides guidance for focusing on individual patient life circumstances that can affect their diabetes management.